Cargando…
Impact of human papillomavirus vaccine on cervical cancer epidemic: Evidence from the surveillance, epidemiology, and end results program
INTRODUCTION: Since 2006, the human papillomavirus (HPV) vaccine has been recommended for females aged 9–26 years in the United States. Aiming to evaluate the early effect of the HPV vaccine on cervical cancer, this study assessed the incidence of cervical cancer by age and histology before and afte...
Autores principales: | Pei, Jiao, Shu, Ting, Wu, Chenyao, Li, Mandi, Xu, Minghan, Jiang, Min, Zhu, Cairong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9859059/ https://www.ncbi.nlm.nih.gov/pubmed/36684904 http://dx.doi.org/10.3389/fpubh.2022.998174 |
Ejemplares similares
-
Molecular Epidemiology of Human Papillomavirus Infection Among Chinese Women With Cervical Cytological Abnormalities
por: Wong, Eliza Lai-Yi, et al.
Publicado: (2022) -
Survival differences between women and men in the non-reproductive cancers: Results from a matched analysis of the surveillance, epidemiology, and end-results program
por: da Luz, Felipe Andrés Cordero, et al.
Publicado: (2023) -
Factors Associated With Patient's Refusal of Recommended Cancer Surgery: Based on Surveillance, Epidemiology, and End Results
por: Hu, Xianglin, et al.
Publicado: (2022) -
Self-Sampling for Human Papillomavirus Testing: Increased Cervical Cancer Screening Participation and Incorporation in International Screening Programs
por: Gupta, Sarah, et al.
Publicado: (2018) -
Epidemiology and Burden of Human Papillomavirus and Related Diseases, Molecular Pathogenesis, and Vaccine Evaluation
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2021)